Sanofi and pCPA Sign Letter of Intent for Dupixent in Four Indications
Sanofi and pCPA have signed a Letter of Intent covering Dupixent across four dermatology and respiratory indications. The bundled negotiation discloses no province list, effective date, or pricing te…